Emergent BioSolutions (EBS) Tops Q3 EPS by 7c
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $8.28 --0%
Revenue Growth %: +32.0%
Financial Fact:
Selling, general and administrative: 40.69M
Today's EPS Names:
CRMT, More
Revenue Growth %: +32.0%
Financial Fact:
Selling, general and administrative: 40.69M
Today's EPS Names:
CRMT, More
Join SI Premium – FREE
Emergent BioSolutions (NYSE: EBS) reported Q3 EPS of $2.19, $0.07 better than the analyst estimate of $2.12. Revenue for the quarter came in at $385.2 million versus the consensus estimate of $437.93 million.
For earnings history and earnings-related data on Emergent BioSolutions (EBS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- Berenberg Starts Brooks Macdonald Group PLC (BRK:LN) at Buy
- Elevance (ELV) PT Raised to $482 at Bernstein SocGen
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
